Enter the first few characters of Company and click 'Go'

Sterling Biotech Ltd. Company History and Annual Growth Details

The Company was incorporated on 23rd March 1985, in Mumbai , India as
Pluto Exports & Consultants Limited and obtained its Certificate of
Commencement of Business on 19 April 1985 under the Companies Act 1956.
The Company changed its name to Sterling Tea and Industries Limited on
24 June 1991 when it entered the tea plantation business. Its name was
a subsequently changed to Sterling Biotech Limited with effect from 29
March registered with the Registrar of Companies in Maharashtra and its
registered office is at 43, Atlanta, Nariman Point, Mumbai 400 021

Mr. Nitin Sandesara, Chairman and Managing Director of the Company
together with his father Mr. J.C. Sandesara, joined the Board of
Directors of the Company in 1989. The present Promoters were amongst
the original investors of the Company, and have held shares since 1985.

2002

-Sterling Biotech commissions expansion project for manufacture of Gelatin.

-Sterling bags an export order for supply of Gelatin.

2003

-Sterling Biotech obtains Rs.5.5cr order for supply of gelatin for Cardiac Health Inc.

-Sterling changes its Biotech symbol from 'STERLINTEA' to 'STERLINBIO'.

-GDR Issue of the company listed on Luxemburg Stock Exchange .

-Issued Global Depository Receipts (GDRs) worth $14.85 million in the international markets.

- Closed the issue of 2,250,000 Global Depository Receipts (GDRs) each representing 6 underlying each shares of Rs.2/- each Offer Price of US$6.60 each aggregating to US$ 14,850,000/-

2004

-Sterling Biotech acquires gelatine biz of Rallis for Rs 47 cr

-HSBC Financial Services (M.E.) Limited acquires 1,67,300 shares amounting to 0.1954% of the total paid up capital of Sterling Boitech Ltd.

- Delists equity shares of the company from the Vadodara Stock Exchange (VSE) with effect from August 16, 2004

2005
- Company has splits its Face value of Shares from Rs 2 to Re 1

2008

-Sterling Biotech Limited has appointed Shri Chetan J. Sandesara as Joint Managing Director of the Company w.e.f. July 15, 2008.

2009

-Sterling Biotech has recommended 50% (Rs 0.50 per equity share of F.V. of Re. 1 /- each)

2010

-Sterling Biotech has recommended 50% (Rs. 0.50 per equity share of F.V. of Re. 1/- each)

2011

-Sterling Biotech has recommended 50% (Rs. 0.50 per equity share of F.V. of Re. 1/- each)

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article